MedTech Innovator

Founded in 2015, DiaMonTech specializes in developing non-invasive medical diagnostic devices. Its proprietary photo-thermal detection technology enables accurate glucose level measurements without finger pricking or blood samples.

CytoVeris develops optical-based technologies that assist surgical oncologists in identifying and removing tumor tissue during cancer resection surgery. Its devices enhance surgeons' ability to achieve clean margins, while its OncoMap system detects molecular signatures unique to cancer cells. Founded by Alan Kersey in Farmington, Connecticut in 2018.

Digma Medical is a clinical stage medical device company focused on innovative treatments for Type-2 Diabetes and related metabolic disorders, including NASH. Founded in 2013, the company is developing the DiaGone™, a disposable endoscopic device that employs advanced laser technology to target the duodenum, the first section of the small intestine. This device is designed to address insulin resistance, the core issue in these diseases. The Duodenal Glycemic Control™ procedure, which lasts approximately 30 minutes, allows gastroenterologists to utilize the DiaGone™ to enhance the body's natural ability to regulate glucose levels. This approach aims to offer patients the potential for long-term remission from Type-2 Diabetes and improve overall health outcomes.

Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.

Deneb Medical develops a laser-based robotic surgery system and a robotic platform for use in neurosurgery, craniofacial and head and neck surgery, urology, and general surgery. The system uses optical and photonic techniques for tissue ablation and includes three-dimensional visualization, augmented reality guidance, and robotic assistance to enable more accurate, efficient, and minimally invasive procedures, with the goal of improving patient outcomes.

Enspectra Health, based in Mountain View, California, develops advanced imaging systems for medical research and diagnosis. Founded in 2012, the company has pioneered the world's first handheld multiphoton imager for human use, capable of visualizing beneath the skin in real-time. Its innovative system combines reflectance confocal and multiphoton laser scanning microscopy to generate multispectral images, enhancing dermatologists' ability to diagnose and treat skin conditions, particularly cancers. Enspectra Health delivers these imaging systems to researchers studying various tissues and has a track record of delivering such systems since its inception.

Founded in 2017, Avenda Health specializes in developing artificial intelligence-based solutions for cancer care. Its flagship product is an FDA-cleared AI platform that integrates various diagnostic data to create synthetic spatial maps of tumors, enhancing clinical decision-making and patient outcomes.